In conclusion, our study clearly indicates that UDS is a valuable tool to reveal small FLT3 ITD mutated clones that may evolve over time and worsen the prognosis of otherwise good prognosis CN-AML patients, and to optimize therapeutic strategies. Here, FLT3 is linked to acute myeloid leukemia.